SONOMA PHARMACEUTICALS, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2021-11-15
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2021-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2020-09-30 was 149.00K shares.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-09-30 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 0.00 shares, a 100.00% decline from fiscal 2014.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2014 was 4.00K shares.
- SONOMA PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-15 | 0.00 shares 10-Q · filed 2021-11-15 | ||
| 2020-09-30 | 149.00K shares 10-Q · filed 2021-11-15 | 192.00K shares 10-Q · filed 2021-11-15 | ||
| 2019-09-30 | 0.00 shares 10-Q · filed 2020-11-20 | 0.00 shares 10-Q · filed 2020-11-20 | ||
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-02-14 | 0.00 shares 10-Q · filed 2018-02-14 | ||
| 2016-12-31 | 3.00K shares 10-Q · filed 2018-02-14 | 0.00 shares 10-Q · filed 2018-02-14 | ||
| 2015-03-31 | 0.00 shares 10-K · filed 2015-06-16 | |||
| 2014-03-31 | 4.00K shares 10-K · filed 2015-06-16 | |||
| 2013-03-31 | 0.00 shares 10-K · filed 2014-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |